Cargando…
The association of (18)F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients
BACKGROUND: Positron emission tomography imaging of lung cancers with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose is a non-invasive diagnostic, and prognostic tool that measures tumor metabolism. We have analyzed the effect of solute carrier family 2 (facilitated glucose transporter), member 1 polymorp...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898683/ https://www.ncbi.nlm.nih.gov/pubmed/20540786 http://dx.doi.org/10.1186/1756-9966-29-69 |
_version_ | 1782183503405776896 |
---|---|
author | Kim, Seong-Jang Hwang, Sang-Hyun Kim, In Joo Lee, Min Ki Lee, Chang Hun Lee, Sang-Yull Lee, Eun Yup |
author_facet | Kim, Seong-Jang Hwang, Sang-Hyun Kim, In Joo Lee, Min Ki Lee, Chang Hun Lee, Sang-Yull Lee, Eun Yup |
author_sort | Kim, Seong-Jang |
collection | PubMed |
description | BACKGROUND: Positron emission tomography imaging of lung cancers with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose is a non-invasive diagnostic, and prognostic tool that measures tumor metabolism. We have analyzed the effect of solute carrier family 2 (facilitated glucose transporter), member 1 polymorphisms on 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-uptake with a combination of polymorphisms of hypoxia-inducible factor 1 alpha, apurinic/apyimidinic endonuclease, and vascular endothelial growth factor A in a hypoxia-related pathway. METHODS: We investigated the association between solute carrier family 2 (facilitated glucose transporter), member 1 -2841A>T, hypoxia-inducible factor 1 alpha Pro582Ser, Ala588Thr, apurinic/apyimidinic endonuclease Asp148Glu, or vascular endothelial growth factor A +936C>T and 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-uptake among 154 patients with non-small-cell lung cancer. RESULTS: The solute carrier family 2 (facilitated glucose transporter), member 1 -2841A>T polymorphism was significantly associated with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-uptake in combination with the apurinic/apyimidinic endonuclease Asp148Glu (T>G) polymorphism in the squamous cell type of non-small-cell lung cancer. The solute carrier family 2 (facilitated glucose transporter), member 1 TT genotype had a higher maximum standardized uptake values than the AA + AT genotype when the apurinic/apyimidinic endonuclease genotype was TT (mean maximum standardized uptake values, 12.47 ± 1.33 versus 8.46 ± 2.90, respectively; P = 0.028). The mean maximum standardized uptake values were not statistically different with respect to vascular endothelial growth factor A and hypoxia-inducible factor 1 alpha polymorphisms. CONCLUSION: A glucose transporter gene polymorphism was shown to be statistically associated with glucose-uptake when the apurinic/apyimidinic endonuclease genotype is TT in patients with the squamous cell type of non-small-cell lung cancer. Our findings suggest that a newly developed tracer for positron emission tomography could be affected by genetic polymorphisms. |
format | Text |
id | pubmed-2898683 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28986832010-07-08 The association of (18)F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients Kim, Seong-Jang Hwang, Sang-Hyun Kim, In Joo Lee, Min Ki Lee, Chang Hun Lee, Sang-Yull Lee, Eun Yup J Exp Clin Cancer Res Research BACKGROUND: Positron emission tomography imaging of lung cancers with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose is a non-invasive diagnostic, and prognostic tool that measures tumor metabolism. We have analyzed the effect of solute carrier family 2 (facilitated glucose transporter), member 1 polymorphisms on 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-uptake with a combination of polymorphisms of hypoxia-inducible factor 1 alpha, apurinic/apyimidinic endonuclease, and vascular endothelial growth factor A in a hypoxia-related pathway. METHODS: We investigated the association between solute carrier family 2 (facilitated glucose transporter), member 1 -2841A>T, hypoxia-inducible factor 1 alpha Pro582Ser, Ala588Thr, apurinic/apyimidinic endonuclease Asp148Glu, or vascular endothelial growth factor A +936C>T and 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-uptake among 154 patients with non-small-cell lung cancer. RESULTS: The solute carrier family 2 (facilitated glucose transporter), member 1 -2841A>T polymorphism was significantly associated with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-uptake in combination with the apurinic/apyimidinic endonuclease Asp148Glu (T>G) polymorphism in the squamous cell type of non-small-cell lung cancer. The solute carrier family 2 (facilitated glucose transporter), member 1 TT genotype had a higher maximum standardized uptake values than the AA + AT genotype when the apurinic/apyimidinic endonuclease genotype was TT (mean maximum standardized uptake values, 12.47 ± 1.33 versus 8.46 ± 2.90, respectively; P = 0.028). The mean maximum standardized uptake values were not statistically different with respect to vascular endothelial growth factor A and hypoxia-inducible factor 1 alpha polymorphisms. CONCLUSION: A glucose transporter gene polymorphism was shown to be statistically associated with glucose-uptake when the apurinic/apyimidinic endonuclease genotype is TT in patients with the squamous cell type of non-small-cell lung cancer. Our findings suggest that a newly developed tracer for positron emission tomography could be affected by genetic polymorphisms. BioMed Central 2010-06-12 /pmc/articles/PMC2898683/ /pubmed/20540786 http://dx.doi.org/10.1186/1756-9966-29-69 Text en Copyright ©2010 Kim et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Kim, Seong-Jang Hwang, Sang-Hyun Kim, In Joo Lee, Min Ki Lee, Chang Hun Lee, Sang-Yull Lee, Eun Yup The association of (18)F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients |
title | The association of (18)F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients |
title_full | The association of (18)F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients |
title_fullStr | The association of (18)F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients |
title_full_unstemmed | The association of (18)F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients |
title_short | The association of (18)F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients |
title_sort | association of (18)f-deoxyglucose (fdg) uptake of pet with polymorphisms in the glucose transporter gene (slc2a1) and hypoxia-related genes (hif1a, vegfa, apex1) in non-small cell lung cancer. slc2a1 polymorphisms and fdg-pet in nsclc patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898683/ https://www.ncbi.nlm.nih.gov/pubmed/20540786 http://dx.doi.org/10.1186/1756-9966-29-69 |
work_keys_str_mv | AT kimseongjang theassociationof18fdeoxyglucosefdguptakeofpetwithpolymorphismsintheglucosetransportergeneslc2a1andhypoxiarelatedgeneshif1avegfaapex1innonsmallcelllungcancerslc2a1polymorphismsandfdgpetinnsclcpatients AT hwangsanghyun theassociationof18fdeoxyglucosefdguptakeofpetwithpolymorphismsintheglucosetransportergeneslc2a1andhypoxiarelatedgeneshif1avegfaapex1innonsmallcelllungcancerslc2a1polymorphismsandfdgpetinnsclcpatients AT kiminjoo theassociationof18fdeoxyglucosefdguptakeofpetwithpolymorphismsintheglucosetransportergeneslc2a1andhypoxiarelatedgeneshif1avegfaapex1innonsmallcelllungcancerslc2a1polymorphismsandfdgpetinnsclcpatients AT leeminki theassociationof18fdeoxyglucosefdguptakeofpetwithpolymorphismsintheglucosetransportergeneslc2a1andhypoxiarelatedgeneshif1avegfaapex1innonsmallcelllungcancerslc2a1polymorphismsandfdgpetinnsclcpatients AT leechanghun theassociationof18fdeoxyglucosefdguptakeofpetwithpolymorphismsintheglucosetransportergeneslc2a1andhypoxiarelatedgeneshif1avegfaapex1innonsmallcelllungcancerslc2a1polymorphismsandfdgpetinnsclcpatients AT leesangyull theassociationof18fdeoxyglucosefdguptakeofpetwithpolymorphismsintheglucosetransportergeneslc2a1andhypoxiarelatedgeneshif1avegfaapex1innonsmallcelllungcancerslc2a1polymorphismsandfdgpetinnsclcpatients AT leeeunyup theassociationof18fdeoxyglucosefdguptakeofpetwithpolymorphismsintheglucosetransportergeneslc2a1andhypoxiarelatedgeneshif1avegfaapex1innonsmallcelllungcancerslc2a1polymorphismsandfdgpetinnsclcpatients AT kimseongjang associationof18fdeoxyglucosefdguptakeofpetwithpolymorphismsintheglucosetransportergeneslc2a1andhypoxiarelatedgeneshif1avegfaapex1innonsmallcelllungcancerslc2a1polymorphismsandfdgpetinnsclcpatients AT hwangsanghyun associationof18fdeoxyglucosefdguptakeofpetwithpolymorphismsintheglucosetransportergeneslc2a1andhypoxiarelatedgeneshif1avegfaapex1innonsmallcelllungcancerslc2a1polymorphismsandfdgpetinnsclcpatients AT kiminjoo associationof18fdeoxyglucosefdguptakeofpetwithpolymorphismsintheglucosetransportergeneslc2a1andhypoxiarelatedgeneshif1avegfaapex1innonsmallcelllungcancerslc2a1polymorphismsandfdgpetinnsclcpatients AT leeminki associationof18fdeoxyglucosefdguptakeofpetwithpolymorphismsintheglucosetransportergeneslc2a1andhypoxiarelatedgeneshif1avegfaapex1innonsmallcelllungcancerslc2a1polymorphismsandfdgpetinnsclcpatients AT leechanghun associationof18fdeoxyglucosefdguptakeofpetwithpolymorphismsintheglucosetransportergeneslc2a1andhypoxiarelatedgeneshif1avegfaapex1innonsmallcelllungcancerslc2a1polymorphismsandfdgpetinnsclcpatients AT leesangyull associationof18fdeoxyglucosefdguptakeofpetwithpolymorphismsintheglucosetransportergeneslc2a1andhypoxiarelatedgeneshif1avegfaapex1innonsmallcelllungcancerslc2a1polymorphismsandfdgpetinnsclcpatients AT leeeunyup associationof18fdeoxyglucosefdguptakeofpetwithpolymorphismsintheglucosetransportergeneslc2a1andhypoxiarelatedgeneshif1avegfaapex1innonsmallcelllungcancerslc2a1polymorphismsandfdgpetinnsclcpatients |